Market Data
Type 1 Diabetes (Juvenile Diabetes) accounts for 7.3% share of global Metabolic Disorders clinical trial activity in 2021
Pancreatic Cancer accounts for 5.8% share of global Oncology clinical trial activity in 2021
Lung Cancer accounts for 16.3% share of global Oncology clinical trial activity in 2021
Epilepsy accounts for 3.7% share of global Central Nervous System clinical trial activity in 2021
Alzheimer’s Disease accounts for 2.8% share of global Central Nervous System clinical trial activity in 2021
Global clinical trials activity decreases 12.2% in Q3 2022 over 4Q average
Global clinical trials activity decreases 15.3% YoY in Q3 2022
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox